OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy
Zhifeng Zou, Lei Yang, Hui-Jun Nie, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1740-1751
Closed Access | Times Cited: 14
Zhifeng Zou, Lei Yang, Hui-Jun Nie, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1740-1751
Closed Access | Times Cited: 14
Showing 14 citing articles:
Metformin-based nanomedicines for reprogramming tumor immune microenvironment
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 26
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 26
A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy
Jing Gao, Xingyu Jiang, Shumin Lei, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Jing Gao, Xingyu Jiang, Shumin Lei, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Target-switchable nanoprobe based on BRD4 inhibition for induction and dynamic visualization of the mitochondrial apoptotic pathway
Ruijie Cao, Yijing Dang, Xinyue Liu, et al.
Biosensors and Bioelectronics (2025) Vol. 273, pp. 117179-117179
Closed Access
Ruijie Cao, Yijing Dang, Xinyue Liu, et al.
Biosensors and Bioelectronics (2025) Vol. 273, pp. 117179-117179
Closed Access
A Dual-Targeted Molecule for Disease-Activatable Proteolysis Targeting Chimeras and Targeted Radionuclide Therapy of Cancer
Yuan Zhang, Wei Gu, Chen Wan, et al.
Journal of the American Chemical Society (2025) Vol. 147, Iss. 9, pp. 7897-7907
Closed Access
Yuan Zhang, Wei Gu, Chen Wan, et al.
Journal of the American Chemical Society (2025) Vol. 147, Iss. 9, pp. 7897-7907
Closed Access
Self‐Oxygenating PROTAC Microneedle for Spatiotemporally‐Confined Protein Degradation and Enhanced Glioblastoma Therapy
Xingyu Jiang, Yi Lai, Wenzheng Xia, et al.
Advanced Materials (2025)
Open Access
Xingyu Jiang, Yi Lai, Wenzheng Xia, et al.
Advanced Materials (2025)
Open Access
Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation
Jiachan Lin, Zirui Chen, Dan Zhang, et al.
Macromolecular Rapid Communications (2025)
Closed Access
Jiachan Lin, Zirui Chen, Dan Zhang, et al.
Macromolecular Rapid Communications (2025)
Closed Access
Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions
Rajamanikkam Kamaraj, Subhrojyoti Ghosh, Souvadra Das, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 8, pp. 1089-1115
Open Access | Times Cited: 3
Rajamanikkam Kamaraj, Subhrojyoti Ghosh, Souvadra Das, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 8, pp. 1089-1115
Open Access | Times Cited: 3
Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment
Mengyao Wu, Yilan Zhao, Chi Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 42, pp. 28502-28530
Closed Access | Times Cited: 1
Mengyao Wu, Yilan Zhao, Chi Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 42, pp. 28502-28530
Closed Access | Times Cited: 1
MicroRNA‐Triggered Programmable DNA‐Encoded Pre‐PROTACs for Cell‐Selective and Controlled Protein Degradation
Jiayin Zhan, Xiang Li, Zhe Feng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
Jiayin Zhan, Xiang Li, Zhe Feng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1
Targeting a key FAK-tor: the therapeutic potential of combining focal adhesion kinase (FAK) inhibitors and chemotherapy for chemoresistant non-small cell lung cancer
Emma Geijerman, Francesca Terrana, Godefridus J. Peters, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1103-1118
Closed Access | Times Cited: 1
Emma Geijerman, Francesca Terrana, Godefridus J. Peters, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1103-1118
Closed Access | Times Cited: 1
Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma
Xuekun Fu, Jie Huang, Xinxin Chen, et al.
Theranostics (2024) Vol. 15, Iss. 1, pp. 103-121
Closed Access | Times Cited: 1
Xuekun Fu, Jie Huang, Xinxin Chen, et al.
Theranostics (2024) Vol. 15, Iss. 1, pp. 103-121
Closed Access | Times Cited: 1
PROTAC delivery in tumor immunotherapy: Where are we and where are we going?
Yiyang Li, Yike Wu, Shugeng Gao, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 116-144
Closed Access | Times Cited: 1
Yiyang Li, Yike Wu, Shugeng Gao, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 116-144
Closed Access | Times Cited: 1
MicroRNA‐Triggered Programmable DNA‐Encoded Pre‐PROTACs for Cell‐Selective and Controlled Protein Degradation
Jiayin Zhan, Xiang Li, Zhe Chuan Feng, et al.
Angewandte Chemie (2024)
Closed Access
Jiayin Zhan, Xiang Li, Zhe Chuan Feng, et al.
Angewandte Chemie (2024)
Closed Access
Precision-engineered PROTACs minimize off-tissue effects in cancer therapy
Jianghua Shi, Luo Wang, Xuanwei Zeng, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Jianghua Shi, Luo Wang, Xuanwei Zeng, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
